Human respiratory uptake of chloroform and haloketones during showering

Chinery R.L., and Gleason A.K. A compartmental model for the prediction of breath concentration and absorbed dose of chloroform after exposure while showering. Risk Anal 1993: 13(1): 51–62.

Clemens M., and Scholer H.F. Halogenated organic compounds in swimming pool water. Zentralblatt Hygiene Umweltmedizin 1992: 193(1): 91–98 (in German).

Comroe J.H. Physiology of Respiration, 2nd edn. Year Book Medical Publishers, Chicago, IL, 1974.

Corley R.A., Mendrala A.L., Smith F.A., Staats D.A., Gargas M.L., Conolly R.B., Anderson M.E., and Reitz R.H. Development of a physiologically based pharmacokinetic model for chloroform. Toxicol Appl Pharmacol 1990: 103(3): 512–527.

Curieux F., Marzin D., and Erb F. Study of the genotoxic activity of five chlorinated propanones using the sos chromotest, the ames-uctuation test and the newt micronucleus test. Mutat Res 1994: 341: 1–15.

Gargas M.L., Burgess R.J., Voisard D.E., Cason G.H., and Andersen M.E. Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol Appl Pharmacol 1989: 98(1): 87–99.

Gordon S.M., Kenny D.V., and Kelly T.J. Continuous real time breath analysis for the measurement of half lives of expired volatile organic compounds. J Expos Anal Environ Epidemiol 1992: 1: 41–54.

Gordon S.M., Wallace L.A., Pellizzari E.D., and O’Neill H.J. Human breath measurements in a clean air chamber to determine half lives for volatile organic compounds. Atmos Environ 1988: 22: 2165–2170.

Hansch C., Leo A., and Hoekman D. Exploring QSAR: Hydrophobic, Electronic, and Steric Constants (ACS Professional Reference Book). American Chemical Society, Washington, DC, 1995.

Heinicke K., Wolfarth B., Winchenbach P., Biermann B., Sehmid A., Huber G., Friedmann B., and Schmidt W. Blood volume and hemoglobin mass in elite athletes of different disciplines. Int J Sports Med 2001: 22(7): 504–512.

Jo W.K., Weisel C.P., and Lioy P.J. Chloroform exposure and the health risk associated with multiple uses of chlorinated tap water. Risk Anal 1990a: 10: 581–585.

Jo W.K., Weisel C.P., and Lioy P.J. Routes of chloroform exposure and body burden from showering with chlorinated tap water. Risk Anal 1990b: 10: 575–580.

Krasner S.W., MeGuire M.J., Jacongelo J.G., Patania N.L., Reagan K.M., and Aieta E.M. The occurrence of disinfection by-products in US drinking water. J AWWA 1989: 81(8): 41–53.

Pinheiro J.C., and Bates D.M. Mixed-effects Models in S and S-PLUS. Springer, New York, 2000.

Pleil J.D., and Lindstrom A.B. Exhaled human breath measurement method for assessing exposure to halogenated volatile organic compounds. Clin Chem 1997: 43(5): 723–730.

Raymer J.H., Pellizzari E.D., Thomas K.W., and Cooper S.D. Elimination of volatile organic compounds in breath after exposure to occupational and environmental microenvironments. J Expos Anal Environ Epidemiol 1991: 1(4): 439–451.

Raymer J.H., Thomas K.W., and Cooper S.D. A device for sampling of human alveolar breath for the measurement of expired volatile organic compounds. J Anal Toxicol 1990: 14(6): 337–344.

Rook J.J. Formation of haloforms during chlorination of natural waters. Water Treat Exam 1974: 23: 234–243.

Sheiner L.B., and Beal S.L. Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis–Menten model: routine clinical pharmacokinetic data. J Pharmacokinet Biopharm 1980a: 8(6): 553–571.

Sheiner L.B., and Beal S.L. Evaluation of methods for estimating population pharmacokinetics parameters. II. Biexponential model: experimental pharmacokinetic data. J Pharmacokinet Biopharm 1980b: 9(5): 635–651.

US EPA. Exposure Factors Handbook, Vol. I: Review Draft. EPA/600/R-95/002Ba. U.S. Environmental Protection Agency, Washington, DC, 1996.

Vinegar A., Williams R.J., Fisher J.W., and McDougal J.N. Dose-dependent metabolism of 2,2-dichloro-1,1,1-triuoroethane: a physiologically based pharmacokinetic model in the male Fischer 344 rat. Toxicol Appl Pharmacol 1994: 29(1): 103–113.

Wallace L.A. Human exposure and body burden for chloroform and other trihalomethanes. Crit Rev Environ Sci Technol 1997: 27(2): 113–194.

Wallace L.A., Nelson W.C., Pellizzari E.D., and Raymer J.H. Uptake and decay of volatile organic compounds at environmental concentrations: application of a four-compartment model to a chamber study of five human subjects. J Expos Anal Environ Epidemiol 1997: 7: 141–163.

Wallace L.A., Pellizzari E.D., and Gordon S.M. A linear model relating breath concentrations to environmental exposures: application to a chamber study of four volunteers exposured to volatile organic chemicals. J Expos Anal Environ Epidemiol 1993: 3: 75–102.

Weisel C.P., and Jo W.K. Ingestion, inhalation, and dermal exposures to chloroform and trichloroethene from tap water. Environ Health Perspect 1996: 104(1): 48–51.

Weisel C.P., Jo W.K., and Lioy P.J. Utilization of breath analysis for exposure and dose estimates of chloroform. J Expos Anal Environ Epidemiol Suppl 1992: 1: 55–69.

Weisel C.P., Xu X., and Trabaris M. Inhalation and dermal exposure to the DBPs: haloacetic acids, halopropanones, haloacetonitriles and chloral hydrate. In: Joint International Society of Exposure Analysis/International Society for Environmental Epidemiology Annual Meeting, August 2002 Vancouver, Canada, 2002: P. 145.

Xu X. Dermal and Inhalation Exposure to Disinfection By-products in “Drinking Water”, PhD thesis, Rutgers University, New Brunswick, NJ, 2002.

Xu X., Mariano T., Laskin J.D., and Weisel C.P. Percutaneous absorption of tri-halomethanes, haloacetic acids and haloketones. Toxicol Appl Pharmacol 2002: 184: 19–26.

Xu X., and Weisel C.P. Inhalation exposure to haloacetic acids and haloketones during showering. Environ Sci Technol 2003: 37(3): 569–576.

Yu R., and Weisel C.P. Measurement of benzene in human breath associated with an environmental exposure. J Expos Anal Environ Epidemiol 1996: 6(1): 261–277.